EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES
We have conducted a study of a novel monoclonal A3 antibody raised by means of hybridoma biotechnology. The study was performed with malignant cells of the patients with various lymphoproliferative disorders, and persons with nonmalignant diseases, as compared with intact lymphocytes from healthy pe...
Main Authors: | N. L. Deineko, T. I. Bulycheva, A. M. Kovrigina, A. A. Grigoriyv |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2014-11-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/730 |
Similar Items
-
Lymphoproliferative disorder involving body fluid: diagnostic approaches and roles of ancillary studies
by: Jiwon Koh, et al.
Published: (2022-07-01) -
The diagnosis of lymphoproliferative diseases /
by: Gatter, Kevin 534567
Published: (c201) -
Application of anti-CD20 monoclonal antibodies in the treatment of lymphoproliferative diseases
by: Pejčić Ivica, et al.
Published: (2009-01-01) -
Histopathological and Clinical Features of Methotrexate-Associated Lymphoproliferative Disorders and Post-Transplant Lymphoproliferative Disorders
by: Preeyawat Ngamdamrongkiat, et al.
Published: (2022-09-01) -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS
by: Pietro Tralongo, et al.
Published: (2024-04-01)